What ANTARES PHARMA, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Greenleaf Peter | Director | May 24 | Disposition to Issuer · D | −49,425 | $5.60 | −$277K | 0 |
| Greenleaf Peter | Director | May 24 | Disposition to Issuer · D | −30,220 | $5.60 | −$169K | 0 |
| Graham Peter J | See Remarks | May 24 | Disposition to Issuer · D | −202,139 | $5.60 | −$1.13M | 0 |
| Graham Peter J | See Remarks | May 24 | Disposition to Issuer · D | −414,470 | $5.60 | −$2.32M | 0 |
| Graham Peter J | See Remarks | May 24 | Disposition to Issuer · D | −124,234 | $5.60 | −$696K | 0 |
| Smith Karen L. | Director | May 24 | Disposition to Issuer · D | −25,452 | $5.60 | −$143K | 0 |
| Smith Karen L. | Director | May 24 | Disposition to Issuer · D | −54,193 | $5.60 | −$303K | 0 |
| Apple Robert F | President and CEO | May 24 | Disposition to Issuer · D | −374,099 | $5.60 | −$2.09M | 0 |
| Apple Robert F | President and CEO | May 24 | Disposition to Issuer · D | −611,667 | $5.60 | −$3.43M | 0 |
| Apple Robert F | President and CEO | May 24 | Disposition to Issuer · D | −1,876,693 | $5.60 | −$10.5M | 0 |
| Powell Fred M | Executive Vice President & CFO | May 24 | Disposition to Issuer · D | −124,234 | $5.60 | −$696K | 0 |
| Powell Fred M | Executive Vice President & CFO | May 24 | Disposition to Issuer · D | −204,022 | $5.60 | −$1.14M | 0 |
| Powell Fred M | Executive Vice President & CFO | May 24 | Disposition to Issuer · D | −587,014 | $5.60 | −$3.29M | 0 |
| Roche Robert P Jr | Director | May 24 | Disposition to Issuer · D | −49,425 | $5.60 | −$277K | 0 |
| Roche Robert P Jr | Director | May 24 | Disposition to Issuer · D | −118,392 | $5.60 | −$663K | 0 |
| Garrity Thomas J | Director | May 24 | Disposition to Issuer · D | −25,452 | $5.60 | −$143K | 0 |
| Richardson Peter C | See Remarks | May 24 | Disposition to Issuer · D | −14,414 | $5.60 | −$80.7K | 0 |
| Richardson Peter C | See Remarks | May 24 | Disposition to Issuer · D | −36,199 | $5.60 | −$203K | 0 |
| Jacob Leonard S | Director | May 24 | Disposition to Issuer · D | −31,674 | $5.60 | −$177K | 0 |
| Jacob Leonard S | Director | May 24 | Disposition to Issuer · D | −138,901 | $5.60 | −$778K | 0 |
Loading...
